SICOT

WEBINAR

HTO vs Unicompartmental Arthroplasty

presented by SICOT

Notification icon This webinar took place on 
http://www.vumedi.com/webinar/hto-vs-unicompartmental-arthroplasty/

Program

David Murray

Professor of Orthopaedics, University of Oxford, UK.

Mobile Unicompartmental Knee Arthroplasty in Young Osteoarthritis Knee

Francesco Benazzo

Professor of Orthopaedics, Fondazione IRCCS Policlinico San Matteo, Italy.

Fixed Unicompartmental Knee Arthroplasty in Young Osteoarthritic Knee

Philipp Lobenhoffer

Professor of Orthopaedic Surgery, Sports Clinic, Germany.

What are the Benefits of High Tibial Osteotomy with Open-wedge Technique in Varus OA of the knee

Hatem Said

Professor of Orthopaedics, Assiut University Hospital, Egypt.

Technical Pearls in Open Wedge High Tibial Osteotomy, Avoiding Complications

Ibrahim Tuncay

Professor of Orthopaedics,Bezmialem Vakif University, Turkey.

Moderator

Faculty:

  • Francesco Benazzo

    Professor of Orthopaedics, Fondazione IRCCS Policlinico San Matteo, Italy.

  • Bill Hamilton

    Assistant Professor of Surgery, Scott & White Health Care, Temple, TX.

  • Philipp Lobenhoffer

    Professor of Orthopaedic Surgery, Sports Clinic, Germany.

  • Hatem Said

    Assistant Professor of Orthopaedics, Assiut University Hospital, Egypt.

Release: 07/01/2014

Expiration: 07/08/2014

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Tibial Osteotomy surgery.

Course Description: In this live webinar, expert Orthopaedic Surgeons will present optimal operable techniques and treatment options to address Tibial Osteotomys. The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

  1. The indications and advantages of unicompartmental arthroplasty for young patients with osteoarthritis
  2. The techniques for successful unicompartmental arthroplasty
  3. Indications and benefits of high tibial osteotomy for medial arthritis in the knee
  4. The Techniques for successful high tibial osteotomy

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the The International Institute for Continuing Medical Education, Inc and VuMedi. The International Institute for Continuing Medical Education, Inc is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. David Murray discloses the following relevant financial relationships with a commercial interest: Royalties from Biomet and Zimmer; Paid consultant for Biomet; Stock or stock options in Bluebelt Technologies;

Dr. Francesco Benazzo discloses the following relevant financial relationships with a commercial interest: Royalties from
Zimmer; Speakers bureau/paid presentations for Zimmer, Fidia, Grunenthal; Paid consultant for Zimmer, Limacorporate; Research support from Limacorporate.

Dr. Philipp Lobenhoffer discloses he has no relevant financial relationships with any commercial interests in relation to this activity.

Dr. Hatem Said discloses he has no relevant financial relationships with any commercial interests in relation to this activity.

Dr. Ibrahim Tuncay discloses the following relevant financial relationships with a commercial interest: Paid consultant for Biomet; Unpaid consultant for Smith & Nephew.

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Dr. David Murray does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Francesco Benazzo does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Philipp Lobenhoffer does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Hatem Said does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Ibrahim Tuncay does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com


40 Comments
Login to view comments. Click here to Login